Trinity Biotech diabetes product approved by FDA
Bray based Trinity Biotech has announced that it has obtained FDA approval for its diabetes diagnosis system, Premier Hb9210.
Bray based Trinity Biotech has announced that it has obtained FDA approval for its diabetes diagnosis system, Premier Hb9210.
The Premier instrument measures HbA1c ora patient's average blood sugar control over the last two to three months and is a key tool in the diagnosis and monitoring of diabetes, the company said in a statement.
FDA approval enables the instrument to be launched and sold in the United States and will greatly facilitate sales...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month, €19.99 Monthly thereafter
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
The year in review
The best writing and and the biggest stories of 2019 from the Business Post
Newsround: What Thursday’s papers say
Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals
More cycle routes, expansion of Luas to Bray and new bus network proposed
Greater Dublin Area draft Transport Strategy published
